AM

Abdul Mustufa

Active Director Director DIN 08334505
DIN 08334505 First appointment Jan 2019 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Jan 2019
Shareholding value Locked Premium profile

About Abdul Mustufa

Abdul Mustufa has 7 years in corporate governance. Holds Director role. Currently with 1 company, including Illoomee Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08334505
Primary Designation Director
First Appointment 17 Jan 2019
Oldest Company Age 7 yrs

Current companies

Company Designation Appointment Founded Status
Director 17 Jan 2019 2019 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Illoomee Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Abdul Mustufa

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abdul Mustufa

Abdul Mustufa has 7 years in corporate governance. Holds Director role. Currently with 1 company, including Illoomee Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Abdul Mustufa is associated with 1 company as Director.

Abdul Mustufa has expertise in General Business.

Abdul Mustufa has 7 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available